| S2178 |
AG-14361 |
AG14361 is a potent inhibitor of PARP1 with Ki of <5 nM. It is at least 1000-fold more potent than the benzamides. |
Selective |
PARP1, Ki: <5 nM |
| S1087 |
Iniparib (BSI-201) |
Iniparib (BSI-201) is a PARP1 inhibitor with demonstrated effectiveness in triple-negative breast cancer (TNBC). Phase 3. |
Selective |
|
| S2197 |
A-966492 |
A-966492 is a novel and potent inhibitor of PARP1 and PARP2 with Ki of 1 nM and 1.5 nM, respectively. |
Pan |
PARP1, EC50: 1 nM; PARP1, Ki: 1 nM |
| S1060 |
Olaparib (AZD2281, Ku-0059436) |
Olaparib (AZD2281, KU0059436) is a selective inhibitor of PARP1/2 with IC50 of 5 nM/1 nM, 300-times less effective against tankyrase-1. Phase 3. |
Pan |
PARP1, IC50: 5 nM |
| S1004 |
Veliparib (ABT-888) |
Veliparib (ABT-888) is a potent inhibitor of PARP1 and PARP2 with Ki of 5.2 nM and 2.9 nM, respectively. It is inactive to SIRT2. Phase 3. |
Pan |
PARP1, Ki: 5.2 nM |
| S7438 |
ME0328 |
ME0328 is a potent and selective PARP inhibitor with IC50 of 0.89 μM for PARP3, about 7-fold selectivity over PARP1. |
Pan |
PARP1, IC50: 6.3 μM |
| S8038 |
UPF 1069 |
UPF 1069 is a selective PARP2 inhibitor with IC50 of 0.3 μM. It is ~27-fold selective against PARP1. |
Pan |
PARP1, IC50: 8.0 μM |